Keywords: sanofi, acomplia, gets, eu, marketing, clearance, hopes

Sanofi's Acomplia gets EU marketing clearance; hopes US appro not far behind

Article | 03 July 2006

Print This

French drug major Sanofi-Aventis has been granted marketing authorization for Acomplia (rimonabant 20mg/day) in all 25 member states of the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in